Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of cefazolin versus cefazolin + gentamicin for prophylaxis of surgical wound infection in CABG
IRCT201201114365N10Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2011
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of cefazolin and gentamicin in surgical site infection (SSI) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Incidence of surgical wound infection. Started Feb 2011; status: completed.
02
Drugs
cefazolingentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT201201114365N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201201114365N10.